Effect of Empagliflozin and Pioglitazone on left ventricular function in patients with type two diabetes and nonalcoholic fatty liver disease without established cardiovascular disease: a randomized single-blind clinical trial

Effect of Empagliflozin and Pioglitazone on left ventricular function in patients with type two diabetes and nonalcoholic fatty liver disease without established cardiovascular disease: a randomized single-blind clinical trial

Abstract Background Nonalcoholic fatty liver disease (NAFLD) is a complex metabolic disorder that increases the risk for cardiovascular disease in patients with type 2 diabetes mellitus (T2DM). Global longitudinal strain (GLS) is an indicator of left ventricular (LV) mechanics and can detect subclin...

Full description

Bibliographic Details
Main Authors: Fereshte Attaran, Sepideh Emami, Masoudreza Sohrabi, Mojtaba Malek, Hossein Ajdarkosh, Mahmoodreza Khoonsari, Faramarz Ismail-Beigi, Mohammad E. Khamseh
Format: Article
Language:English
Published: BMC 2023-09-01
Series:BMC Gastroenterology
Subjects:
Empagliflozin
Pioglitazone
Ventricular function
Liver cirrhosis
Non-alcoholic fatty liver disease
Heart, heart failure
Online Access:https://doi.org/10.1186/s12876-023-02948-4

Internet

https://doi.org/10.1186/s12876-023-02948-4

Similar Items